JP2008531746A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531746A5 JP2008531746A5 JP2008500768A JP2008500768A JP2008531746A5 JP 2008531746 A5 JP2008531746 A5 JP 2008531746A5 JP 2008500768 A JP2008500768 A JP 2008500768A JP 2008500768 A JP2008500768 A JP 2008500768A JP 2008531746 A5 JP2008531746 A5 JP 2008531746A5
- Authority
- JP
- Japan
- Prior art keywords
- tweak
- antibody
- receptor
- tweak receptor
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65933905P | 2005-03-07 | 2005-03-07 | |
| PCT/US2006/007547 WO2006096487A2 (en) | 2005-03-07 | 2006-03-02 | Methods and compositions for modulating tweak and fn14 activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013271694A Division JP2014111605A (ja) | 2005-03-07 | 2013-12-27 | Ｔｗｅａｋ及びｆｎ１４活性を調節するための方法及び組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008531746A JP2008531746A (ja) | 2008-08-14 |
| JP2008531746A5 true JP2008531746A5 (https=) | 2009-04-16 |
Family
ID=36953868
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008500768A Withdrawn JP2008531746A (ja) | 2005-03-07 | 2006-03-02 | Ｔｗｅａｋ及びｆｎ１４活性を調節するための方法及び組成物 |
| JP2013271694A Pending JP2014111605A (ja) | 2005-03-07 | 2013-12-27 | Ｔｗｅａｋ及びｆｎ１４活性を調節するための方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013271694A Pending JP2014111605A (ja) | 2005-03-07 | 2013-12-27 | Ｔｗｅａｋ及びｆｎ１４活性を調節するための方法及び組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20080286271A1 (https=) |
| EP (1) | EP1853312B1 (https=) |
| JP (2) | JP2008531746A (https=) |
| KR (3) | KR20130089271A (https=) |
| CN (2) | CN101171035A (https=) |
| AU (1) | AU2006220825A1 (https=) |
| BR (1) | BRPI0608012A2 (https=) |
| CA (1) | CA2597485A1 (https=) |
| IL (1) | IL185180A0 (https=) |
| RU (1) | RU2007137060A (https=) |
| WO (1) | WO2006096487A2 (https=) |
| ZA (1) | ZA200707489B (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5550799B2 (ja) | 1999-01-15 | 2014-07-16 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | Ｔｗｅａｋのアンタゴニストおよびｔｗｅａｋレセプターのアンタゴニスト、ならびに免疫学的障害を処置するためのこれらの使用 |
| US7208151B2 (en) | 2001-09-12 | 2007-04-24 | Biogen Idec Ma Inc. | Tweak receptor agonists as anti-angiogenic agents |
| EA011607B1 (ru) | 2002-04-09 | 2009-04-28 | Байоджен Айдек Ма Инк. | Способ лечения заболеваний, связанных с tweak |
| EP2529619B1 (en) | 2005-02-17 | 2015-09-23 | Biogen MA Inc. | Treating neurological disorders |
| US20090068102A1 (en) * | 2005-02-17 | 2009-03-12 | Biogen Idec Ma Inc. | Treating stroke |
| WO2006096487A2 (en) * | 2005-03-07 | 2006-09-14 | Genentech, Inc. | Methods and compositions for modulating tweak and fn14 activity |
| JP5339901B2 (ja) * | 2005-05-10 | 2013-11-13 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 炎症傷害の処置および評価 |
| DK1888113T3 (da) * | 2005-05-27 | 2014-09-01 | Biogen Idec Inc | Tweak-bindende antistoffer |
| WO2006130429A2 (en) * | 2005-05-27 | 2006-12-07 | Biogen Idec Ma Inc. | Treatment of cancer |
| WO2006138219A2 (en) | 2005-06-13 | 2006-12-28 | Biogen Idec Ma Inc. | Methods of diagnosis / prognosis of inflammatory conditions |
| WO2008048924A2 (en) * | 2006-10-16 | 2008-04-24 | Biogen Idec Ma Inc. | Biomarkers of multiple sclerosis |
| WO2009020933A2 (en) * | 2007-08-03 | 2009-02-12 | Facet Biotech Corporation | Therapeutic use of anti-tweak receptor antibodies |
| US8093006B2 (en) | 2009-04-02 | 2012-01-10 | Hoffmann-La Roche Inc. | Antibodies against human tweak and uses thereof |
| US20120055055A1 (en) * | 2010-09-02 | 2012-03-08 | Illumin8 Outdoor Media, LLC | Systems and Method for Outdoor Media Signage |
| KR101584416B1 (ko) * | 2010-10-05 | 2016-01-13 | 에프. 호프만-라 로슈 아게 | 인간 tweak에 대한 항체 및 그의 용도 |
| CA2827759C (en) | 2011-03-10 | 2018-10-16 | Omeros Corporation | Generation of anti-fn14 monoclonal antibodies by ex-vivo accelerated antibody evolution |
| JP2016000003A (ja) * | 2013-04-19 | 2016-01-07 | アステラス製薬株式会社 | 新規抗ヒトｔｗｅａｋ抗体 |
| CN105779576B (zh) * | 2014-12-25 | 2025-01-17 | 中国人民解放军第四军医大学 | 人tnfrsf12a基因的用途及其相关药物 |
| EP3548097A4 (en) | 2016-12-02 | 2020-07-01 | Avelas Biosciences, Inc. | NERVE MARKING COMPOSITIONS AND USES THEREOF |
| MX2021004976A (es) * | 2018-10-31 | 2021-06-15 | Astellas Pharma Inc | Anticuerpo fn14 antihumano. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001513626A (ja) * | 1997-02-12 | 2001-09-04 | アボツト・ラボラトリーズ | 疾患の治療及び診断のために有用なｔｎｆファミリーのメンバー |
| JP5550799B2 (ja) * | 1999-01-15 | 2014-07-16 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | Ｔｗｅａｋのアンタゴニストおよびｔｗｅａｋレセプターのアンタゴニスト、ならびに免疫学的障害を処置するためのこれらの使用 |
| ATE363489T1 (de) * | 1999-03-08 | 2007-06-15 | Genentech Inc | In tumoren vervielfältigte gensequenzen und deren diagnostische verwendungen |
| US7442776B2 (en) * | 1999-10-08 | 2008-10-28 | Young David S F | Cancerous disease modifying antibodies |
| US6727225B2 (en) * | 1999-12-20 | 2004-04-27 | Immunex Corporation | TWEAK receptor |
| EP1239869B1 (en) * | 1999-12-20 | 2013-08-28 | Immunex Corporation | Tweak receptor |
| EP2260867A1 (en) * | 2000-09-14 | 2010-12-15 | Biogen Idec MA Inc. | TWEAK receptor agonists as anti-angiogenic agents |
| CA2427858A1 (en) * | 2000-11-03 | 2002-05-10 | University Of Vermont And State Agricultural College | Compositions for inhibiting grb7 |
| US7393531B2 (en) * | 2003-01-21 | 2008-07-01 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| CA2587018A1 (en) * | 2004-11-08 | 2006-05-18 | University Of Maryland, Baltimore | Tweak as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death |
| WO2006096487A2 (en) * | 2005-03-07 | 2006-09-14 | Genentech, Inc. | Methods and compositions for modulating tweak and fn14 activity |
-
2006
- 2006-03-02 WO PCT/US2006/007547 patent/WO2006096487A2/en not_active Ceased
- 2006-03-02 CN CNA2006800155970A patent/CN101171035A/zh active Pending
- 2006-03-02 AU AU2006220825A patent/AU2006220825A1/en not_active Abandoned
- 2006-03-02 KR KR1020137015784A patent/KR20130089271A/ko not_active Withdrawn
- 2006-03-02 CN CN2011101610523A patent/CN102225200A/zh active Pending
- 2006-03-02 ZA ZA200707489A patent/ZA200707489B/xx unknown
- 2006-03-02 KR KR20157002807A patent/KR20150031459A/ko not_active Ceased
- 2006-03-02 EP EP06736808.4A patent/EP1853312B1/en not_active Revoked
- 2006-03-02 US US11/908,074 patent/US20080286271A1/en not_active Abandoned
- 2006-03-02 BR BRPI0608012-0A patent/BRPI0608012A2/pt not_active Application Discontinuation
- 2006-03-02 RU RU2007137060/14A patent/RU2007137060A/ru unknown
- 2006-03-02 CA CA002597485A patent/CA2597485A1/en not_active Abandoned
- 2006-03-02 JP JP2008500768A patent/JP2008531746A/ja not_active Withdrawn
- 2006-03-02 KR KR1020077020346A patent/KR20070108537A/ko not_active Withdrawn
-
2007
- 2007-08-09 IL IL185180A patent/IL185180A0/en unknown
-
2011
- 2011-11-21 US US13/300,897 patent/US20120269808A1/en not_active Abandoned
-
2013
- 2013-12-27 JP JP2013271694A patent/JP2014111605A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008531746A5 (https=) | ||
| JP6901493B2 (ja) | 抗ｂｃｍａポリペプチド及びタンパク質 | |
| JP5837730B2 (ja) | 抗インターフェロンアルファモノクローナル抗体及び使用方法 | |
| CA3108915A1 (en) | Proteins binding nkg2d, cd16 and a tumor-associated antigen | |
| CA2558371C (en) | Methods of modulating immune responses by modulating tim-1 and tim-4 function | |
| PL207501B1 (pl) | Zastosowanie polipeptydu BCMA oraz przeciwciała skierowanego przeciwko BCMA | |
| KR20140036267A (ko) | Fc 수용체 결합 단백질 | |
| Benucci et al. | Tumor necrosis factors blocking agents: analogies and differences | |
| KR20200058322A (ko) | 항-pd-l1 항체 및 il-7 융합체 | |
| KR20190115042A (ko) | 활성 강직성 척추염의 치료를 위한 항-tnf 항체, 조성물, 및 방법 | |
| CN101675078A (zh) | CRIg拮抗剂 | |
| US11773177B2 (en) | Variant antibodies that bind OX40 | |
| US20220288226A1 (en) | Methods and compositions to treat autoimmune diseases and cancer | |
| CN116847887A (zh) | 治疗自身免疫性疾病和癌症的方法和组合物 | |
| RU2007137060A (ru) | Способы и композиции для модуляции активности tweak и fn14 | |
| Dörner et al. | B-cell targeting: a novel approach to immune intervention today and tomorrow | |
| TW200948377A (en) | Affinity matured CRIg variants | |
| TW202336035A (zh) | 治療自體免疫疾病及癌症之方法及組成物 | |
| WO2010081787A1 (en) | IMPROVED TNFα ANTAGONISM, PROPHYLAXIS & THERAPY WITH REDUCED ORGAN NECROSIS | |
| Scheinberg et al. | The potential role of blisibimod for the treatment of systemic lupus erythematosus | |
| HK40000997A (en) | Pan-elr+ cxc chemokine antibodies | |
| HK40000997B (en) | Pan-elr+ cxc chemokine antibodies | |
| Das | Characterisation of heteromers and oligomers in the TNF family of ligands and receptors |